- Home
- AQB vs INM Comparison
AQB vs INM Comparison
Compare AQB & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQB
- INM
- Stock Information
- Founded
- AQB 1991
- INM 1981
- Country
- AQB United States
- INM Canada
- Employees
- AQB N/A
- INM N/A
- Industry
- AQB
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- AQB
- INM Health Care
- Exchange
- AQB Nasdaq
- INM Nasdaq
- Market Cap
- AQB 2.8M
- INM 3.2M
- IPO Year
- AQB N/A
- INM N/A
- Fundamental
- Price
- AQB $0.75
- INM $2.24
- Analyst Decision
- AQB
- INM
- Analyst Count
- AQB 0
- INM 0
- Target Price
- AQB N/A
- INM N/A
- AVG Volume (30 Days)
- AQB 48.3K
- INM 141.0K
- Earning Date
- AQB 08-05-2025
- INM 09-29-2025
- Dividend Yield
- AQB N/A
- INM N/A
- EPS Growth
- AQB N/A
- INM N/A
- EPS
- AQB N/A
- INM N/A
- Revenue
- AQB N/A
- INM $4,920,990.00
- Revenue This Year
- AQB N/A
- INM N/A
- Revenue Next Year
- AQB N/A
- INM N/A
- P/E Ratio
- AQB N/A
- INM N/A
- Revenue Growth
- AQB N/A
- INM N/A
- 52 Week Low
- AQB $0.47
- INM $1.72
- 52 Week High
- AQB $1.62
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- AQB 47.54
- INM 34.31
- Support Level
- AQB $0.71
- INM $2.31
- Resistance Level
- AQB $0.75
- INM $2.71
- Average True Range (ATR)
- AQB 0.03
- INM 0.10
- MACD
- AQB -0.00
- INM -0.03
- Stochastic Oscillator
- AQB 34.64
- INM 7.27
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.